Background-Formoterol, a new 12 agonist, is long and fast acting when given as an aerosol. The aim was to determine the onset and duration of bronchodilatation with formoterol as a dry powder compared with salbutamol dry powder and with placebo. (Thorax 1993;48:611-614) Formoterol is a potent and highly selective 82 adrenoceptor agonist1 2 which has been used in Japan for several years as an oral preparation.3 Surprisingly, a study by L6fdahl and Svedmyr showed that inhaled formoterol produced a much more long lasting bronchodilatation than oral formoterol.4 Several groups then confirmed that formoterol administered as an aerosol from a metered dose inhaler causes rapid bronchodilatation and an effect lasting for at least 12 hours.9-Up to a year's treatment provides good control of asthma without inducing tachyphylaxis. 912 We investigated the efficacy of administering formoterol through a dry powder inhaler.
caused bronchodilatation as rapidly as salbutamol 400 jg. Peak values were not significantly different in the active treatments. The duration of action, calculated as median time with 20% or more of the maximum achieved increase in FEV1, was sustained for 9 hours and 16 minutes with salbutamol 400 jg, for 9 hours and 45 minutes with formoterol 6jpg, for 11 hours and 22 minutes with formoterol 12 ug, and for 11 hours and 42 minutes with formoterol 24 pg.
Conclusions-Formoterol as a dry powder at doses of 12 pig and 24 ug produces a rapid onset of action and has a bronchodilator effect comparable with salbutamol 400 jg as a dry powder. The bronchodilatation was sustained for 11-12 hours. Formoterol 6 pg caused similar bronchodilatation but more slowly and for a shorter time. (Thorax 1993; 48:611-614) Formoterol is a potent and highly selective 82 adrenoceptor agonist1 2 which has been used in Japan for several years as an oral preparation.3 Surprisingly, a study by L6fdahl and Svedmyr showed that inhaled formoterol produced a much more long lasting bronchodilatation than oral formoterol.4 Several groups then confirmed that formoterol administered as an aerosol from a metered dose inhaler causes rapid bronchodilatation and an effect lasting for at least 12 hours.9-Up to a year's treatment provides good control of asthma without inducing tachyphylaxis. 912 We investigated the efficacy of administering formoterol through a dry powder inhaler.
The use of inhaled f2 agonists in dry powder form has been increasing. Dry powder inhalers eliminate most of the coordination problems of aerosol inhalers and freon propellants are not needed, which is beneficial for the environment. We measured the bronchodilator effect, as well as the onset and duration of action, of three different doses of formoterol dry powder compared with 400 pg salbutamol dry powder and placebo. 
Discussion
The onset of bronchodilatation, measured as sGaw, was almost identical with formoterol 12 pg and 24 pg and salbutamol, the classic reference drug used for rescue treatment. The maximal bronchodilatation achieved was also similar for the two drugs. This is in agreement with studies using formoterol from metered dose inhalers by Derom et a16 and Maesen et al. 7 Thirty minutes after treatment all active drugs had almost reached their maximum bronchodilatation, and there was no significant difference between values 30 minutes, one hour, or two hours after treatment.
The duration of bronchodilatation for formoterol dry powder was as expected significantly longer than for the shorter acting salbutamol and placebo. Formoterol 12 pug and 24 pg had similar duration of action, whereas it was slightly shorter for formoterol 6 pg. A common way to express duration of bronchodilatation is as the length of time the FEVy is 15% or more above baseline values. We chose the method described by Arvidsson et al 13 and have expressed the duration as the median time with 20% or more of the maximum achieved bronchodilatation because the asthma was moderately reversible in our subjects. With this descriptive method the duration of bronchodilatation was 11-12 hours for formoterol 12 pg and 24 pg, which is similar to the results in studies on inhaled formoterol from metered dose inhalers.s
We conclude that formoterol dry powder 12 pg and 24 pg had a rapid onset of action and a bronchodilator effect comparable with that of salbutamol 400 ,g dry powder. The bronchodilatation was prolonged for up to 11-12 hours. There was a dose-response relation, with shorter duration and slower onset for formoterol 6 pg. Formoterol 12 pg seems to be the most favourable dose, but because variation in the duration of bronchodilatation is large between subjects there may be a need for more than one recommended dose for clinical practice.
This study was presented in abstract form at the annual meeting of the American Thoracic Society in Anaheim, California, in May 1991. smooth muscle cells, endothelial cells, and cells of the immune system (macrophages, lymphocytes, and mast cells). The chapters cover the role of cytokines, G proteins, protein kinases, and phosphatases in a way that may be more relevant to the clinical scientist. In summary, this is predominantly a reference book to be dipped into rather than read, except by the dedicated or training scientist in the field. However, the mechanisms involved are going to be relevant to all scientists studying cell biology whatever their disease or cell of interest. Some sections, however, would undoubtedly benefit from some or more simple diagrams or tables. Nevertheless this volume is a welcome addition to the series, although its topic and overall price will lead to a restricted market. It 
